Group Antenatal Care: Effectiveness for Maternal/Infant and HIV Prevention Outcomes and Contextual Factors Linked to Implementation Success in Malawi
团体产前护理:孕产妇/婴儿和艾滋病毒预防成果的有效性以及与马拉维实施成功相关的背景因素
基本信息
- 批准号:9768579
- 负责人:
- 金额:$ 61.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-22 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAddressAdoptedAffectAfricaAfrica South of the SaharaAfricanAnemiaBehaviorBlood PressureBreast FeedingBypassCaringChildClientClinicClinical Trials Cooperative GroupConsultContinuity of Patient CareCountryDataDistressEffectivenessEnsureExclusive BreastfeedingExposure toFailureFamily PlanningFemale of child bearing ageGovernmentHIVHIV InfectionsHIV SeronegativityHIV SeropositivityHealthHealth PolicyHealth PrioritiesHealth PromotionHealth systemHemorrhageHourHuman immunodeficiency virus testHybridsHypertensionIndividualInfantInfant MortalityIntakeInterventionKnowledgeLate pregnancyLengthLettersLifeLinkLow Birth Weight InfantMalawiMaternal MortalityMidwifeModelingMonitorMorbidity - disease rateMothersNeonatalNeonatal MortalityOutcomePerinatal mortality demographicsPlayPoliciesPostpartum PeriodPre-EclampsiaPregnancyPremature BirthPrenatal carePrevalenceProcessProviderPsyche structurePublic HealthQuality of CareRandomizedRandomized Clinical TrialsResearchResourcesRiskRoleSafe SexSavingsSelf AssessmentServicesSex BehaviorSiteSurveysTanzaniaTestingTimeVisitWeightWomanantenatalantiretroviral therapyburnoutcontextual factorscostdesigneffectiveness trialevidence baseexperienceglobal healthhealth care service utilizationhealth recordimprovedinnovationmortalitynovelpatient orientedperinatal HIVprematureprimary outcomesatisfactionscale upsecondary outcomestillbirthsuccesstransmission processtreatment as usualuptake
项目摘要
Sub-Saharan Africa has the world's highest rates of maternal and perinatal mortality and accounts for 2/3 of
new HIV infections and 1/4 of preterm births. Antenatal (prenatal) care is the entry point into the health system
for many women and offers a unique opportunity to provide life-saving monitoring. However, provider
shortages, low quality of care and failure to attend all recommended visits mean that the potential benefits of
antenatal care are not realized. There is an urgent need to test novel interventions to reduce health risks for
mother and child. Group antenatal care is a transformative model of care that provides a positive pregnancy
experience, uses provider time efficiently, and improves perinatal and HIV-related outcomes. Women in group
antenatal care have 2-hour visits with the same provider in a group of 8-12 women at a similar stage of
pregnancy. Women conduct self-assessments, briefly consult the midwife, and meet for 80-90 minutes of
interactive health promotion enlivened by games and role-plays. Women form relationships with midwives and
each other. In a US randomized clinical trial (RCT), group care improved prematurity rates, antenatal care
attendance, satisfaction with care, breastfeeding practices, safer sex behaviors, and uptake of family planning.
Our randomized pilot in Malawi and Tanzania had promising outcomes. More women in group care than in
usual care completed ≥4 antenatal visits (94% vs 58%). Their partners were more likely to be tested for HIV
during pregnancy (51% vs. 27%). We established that group antenatal care can be offered in a rigorous RCT
with high fidelity despite provider shortages. The next step is an adequately powered effectiveness trial.
Malawi is an especially appropriate site because it has the world's highest prematurity rate (18%) and high HIV
prevalence (10% nationally, 16% at the study site). We use a hybrid design to simultaneously conduct an
effectiveness RCT with individual-level randomization and examine implementation processes at 6 clinics in
Blantyre District, Malawi. Aim 1 is to evaluate the effectiveness of group antenatal care through 6 months
postpartum. We hypothesize that compared to usual care, women in group care and their infants will have less
morbidity and mortality and more positive HIV prevention outcomes. We test Aim 1 hypotheses using multi-
level hierarchical models using data from repeated surveys and health records. Aim 2 is to identify clinic-level
degree of implementation success and contextual factors associated with success for each clinic and across
clinics. Analyses use within and across-case matrices. This high-impact study addresses three global health
priorities, maternal and infant mortality and HIV prevention, that affect all women of childbearing age in Malawi.
The Ministry of Health strongly supports this project; results will help them decide whether to scale-up this
innovative model of group care. Negative results will avoid spending on ineffective care. Positive results will
provide evidence needed to adopt group antenatal care nationally and in other low-resource countries.
撒哈拉以南非洲的孕产妇和围产儿死亡率是世界上最高的,占世界人口的三分之二
新的艾滋病毒感染和1/4的早产。产前护理是进入卫生系统的切入点。
对于许多妇女来说,这是一个独特的机会,可以提供拯救生命的监测。但是,提供商
短缺、护理质量低以及未能参加所有建议的就诊意味着
没有实现产前护理。迫切需要测试新的干预措施,以降低
母亲和孩子。集体产前护理是一种提供积极妊娠的变革性护理模式
经验,有效地利用提供者的时间,改善围产期和艾滋病毒相关的结局。团体中的女性
在8-12名处于类似阶段的妇女中,产前护理人员与同一提供者进行2小时的访问
怀孕了。女性进行自我评估,简要咨询助产士,并与助产士会面80-90分钟
通过游戏和角色扮演来活跃互动的健康促进。女性与助产士建立关系,并
彼此之间。在一项美国随机临床试验(RCT)中,团体护理改善了早产儿发生率,产前护理
出勤率、对护理的满意度、母乳喂养做法、安全性行为和接受计划生育。
我们在马拉维和坦桑尼亚的随机试验取得了有希望的结果。参加团体护理的女性多于参加团体护理的女性
常规护理完成了≥4产前检查(94%对58%)。他们的伴侣更有可能接受艾滋病毒检测
怀孕期间(51%对27%)。我们确定,集体产前护理可以在严格的随机对照试验中提供
尽管供应商短缺,但仍保持高保真。下一步是进行动力充足的有效性试验。
马拉维是一个特别合适的地方,因为它有世界上最高的早产率(18%)和高艾滋病毒
患病率(全国为10%,研究地点为16%)。我们使用混合设计来同时进行
采用个人水平随机抽样的有效性随机对照试验,并在#年的6个诊所检查实施过程
马拉维布兰太尔区。目的1是通过6个月评价团体产前护理的效果。
产后。我们假设,与常规护理相比,团体护理中的妇女及其婴儿将有更少的
发病率和死亡率以及更积极的艾滋病毒预防成果。我们测试目标1假设使用多个-
使用来自重复调查和健康记录的数据来分级分层模型。目标2是确定临床水平
每个诊所和整个诊所的实施成功程度和与成功相关的背景因素
诊所。分析使用案例内和案例间的矩阵。这项影响很大的研究涉及三个全球健康问题
影响马拉维所有育龄妇女的优先事项--孕产妇和婴儿死亡率以及艾滋病毒预防。
卫生部强烈支持这一项目;结果将帮助他们决定是否扩大这一项目
创新团体照护模式。负面结果将避免花费在无效的医疗保健上。积极的结果将
提供在全国和其他低资源国家采用集体产前护理所需的证据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Crystal Lauren Patil其他文献
Crystal Lauren Patil的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Crystal Lauren Patil', 18)}}的其他基金
Group Antenatal Care: Effectiveness for Maternal/Infant and HIV Prevention Outcomes and Contextual Factors Linked to Implementation Success in Malawi
团体产前护理:孕产妇/婴儿和艾滋病毒预防成果的有效性以及与马拉维实施成功相关的背景因素
- 批准号:
10163271 - 财政年份:2018
- 资助金额:
$ 61.99万 - 项目类别:
Integrating HIV with Innovative Group Antenatal Care in Two African Countries
在两个非洲国家将艾滋病毒与创新的团体产前护理相结合
- 批准号:
8540640 - 财政年份:2013
- 资助金额:
$ 61.99万 - 项目类别:
Integrating HIV with Innovative Group Antenatal Care in Two African Countries
在两个非洲国家将艾滋病毒与创新的团体产前护理相结合
- 批准号:
8736012 - 财政年份:2013
- 资助金额:
$ 61.99万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 61.99万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 61.99万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 61.99万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 61.99万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 61.99万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 61.99万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 61.99万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 61.99万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 61.99万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 61.99万 - 项目类别:
Research Grant